• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2015 Fiscal Year Final Research Report

Pathophysiological roles of M1 aminopeptidases

Research Project

  • PDF
Project/Area Number 25293083
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypePartial Multi-year Fund
Section一般
Research Field Pathological medical chemistry
Research InstitutionTeikyo Heisei University

Principal Investigator

TSUJIMOTO Masafumi  帝京平成大学, 薬学部, 教授 (00281668)

Co-Investigator(Kenkyū-buntansha) TAKASU Kiyosei  京都大学, 薬学研究院, 教授 (10302168)
HATTORI Akira  京都大学, 薬学研究院, 准教授 (50300893)
OGAWA Yuko  帝京平成大学, 薬学部, 准教授 (30267330)
GOTO Yoshikuni  帝京平成大学, 薬学部, 講師 (90455345)
OGAWA Kenji  独立行政法人理化学研究所, 専任研究員 (50251418)
Project Period (FY) 2013-04-01 – 2016-03-31
KeywordsM1アミノペプチダーゼ / 小胞体アミノペプチダーゼ / ノックアウトマウス / 一酸化窒素
Outline of Final Research Achievements

Endoplasmic reticulum aminopeptidase (ERAP)1 was secreted under infectious conditions. When analyzed the mechanism, several cytokines were expressed in macrophages in response to LPS and IFN-gamma and their synergistic action caused the secretion via induction of calcium mobilization. Then we found that ERAP1 contributed to the NO production in vivo when analyzed by employing ERAP1-knockout mice.
In the serum of knockout mice, decrease in free arginine level was observed, suggesting that ERAP1 caused the cleavage of N-terminal arginine of substrate peptides and thus increased NO production. Further works are now in progress to elucidate the pathophysiological roles of ERAP1.
By molecular modeling, we elucidated the characteristic features of the substrate pocket of M1 aminopeptidases. Based on these results, we screened the inhibitor of ERAP1 and found a candidate. After optimization, we will develop a therapeutically useful inhibitor to pathological conditions caused by ERAP1.

Free Research Field

生化学

URL: 

Published: 2017-05-10  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi